CD25 | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Regulatory Trial results

25 July 2024

Roche’s Skyscraper looks on shaky foundations

Roche curbs its TIGIT push, while a co-stimulation crunch could be bad news for Regeneron.

Subscribe to CD25